Associate Director, Heme Global Business Systems

Scorpion Therapeutics; Boston (MA); Hybrid; USD 180,000 - 240,000; Full time

Benefits offered by this job

Hybrid work arrangement

Job summary

Scorpion Therapeutics seeks an Associate Director, Heme CGT Business Systems, to lead global system strategies for CASGEVY, a CRISPR-based autologous gene therapy for Sickle Cell Disease and beta thalassemia. You will partner across IT, clinical operations, and commercial teams to deliver scalable digital tools.

Hybrid work model with on-site Boston presence; the role emphasizes GxP compliance, cross‑functional collaboration, and global expansion across markets.

Qualifications

• 8+ years of digital program delivery in regulated environments (GxP).
• Experience with GxP systems, digital transformation and system integrations.
• Strong analytical, strategic planning, and simplification skills.

Responsibilities

• Developing product roadmaps and collaborating with IT and regional stakeholders to implement scalable commercial tools.
• Ensuring GxP compliance and driving process improvements across international and US teams involved in therapy delivery.

Skills

Digital program delivery

GxP systems

Strategic planning

Stakeholder engagement

Data-driven decision making

Education

Bachelor's degree

Tools

System integrations

Job description

Role:

Associate Director, Heme CGT Business Systems, responsible for leading global system strategies for CASGEVY, a CRISPR-based autologous gene therapy for Sickle Cell Disease and beta thalassemia.

Responsibilities:

Developing product roadmaps, collaborating with IT and regional stakeholders to implement scalable commercial tools, ensuring GxP compliance, and driving process improvements across international and US teams involved in therapy delivery.

Qualifications:

Bachelor's degree, 8+ years in digital program delivery within regulated environments, with experience in GxP systems, digital transformation, and system integrations. Strong analytical, strategic planning, and simplification skills are essential.

High-value details:

Focus on cell and gene therapy modality, advanced therapy medicinal product (ATMP), global scale with multi-market expansion, emphasis on commercial operations, GxP regulation, and cross-functional stakeholder engagement.

Work setup:

Hybrid on-site in Boston, with flexible work arrangements.